Consensus Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:03 18/02/2026 GMT			5-day change	1st Jan Change
126.94 ^USD	+2.48%		-1.52%	-6.71%

02-11	Agilent Technologies Inc. Announces Cash Dividend, Payable on April 22, 2026	CI
02-11	Agilent presents Boehringer Ingelheim with inaugural 2025 instrument Trade-in Impact Award	RE

Evolution of the Average Target: Agilent Technologies, Inc.

Evolution of the Target Price: Agilent Technologies, Inc.

Changes in Analyst Recommendations: Agilent Technologies, Inc.

a1658.RGzRhCcRC8hWpCoqBA79oj25Pl46ALYZtimlW87LtxE.Mjq3t0J4Zvwm8hNmR025yQX_egdgRfNM6UDkYoyP3GsuAJj9V1o6iTmTHg~2695fa550c1c85d3fd4400c7e7a18027

Analysts' recommendations: Agilent Technologies, Inc.

01-20	HSBC Initiates Agilent Technologies at Buy With $180 Price Target	MT
01-06	Evercore ISI Upgrades Agilent Technologies to Outperform From In Line, Adjusts PT to $160 From $155	MT
12-15	Barclays Upgrades Agilent Technologies to Overweight From Equalweight, Price Target is $165	MT
12-15	Analyst recommendations: Adobe, Hilton, Oracle, ServiceNow, ZoomInfo…
12-03	Morgan Stanley Initiates Agilent Technologies at Overweight With $180 Price Target	MT
12-02	Agilent, Waters Face Diverging Outlooks on Growth and Integration Risks, Morgan Stanley Says	MT
12-02	Morgan Stanley Initiates Agilent Technologies at Overweight With $180 Price Target	MT
12-01	Rothschild & Co Redburn Adjusts Price Target on Agilent Technologies to $180 From $165, Maintains Buy Rating	MT
11-25	Stifel Nicolaus Adjusts Agilent Technologies PT to $170 From $151, Maintains Buy Rating	MT
11-25	UBS Adjusts Agilent Technologies Price Target to $180 From $170, Maintains Buy Rating	MT
11-25	TD Cowen Adjusts Agilent Technologies Price Target to $170 From $162, Maintains Buy Rating	MT
11-25	Jefferies Adjusts Price Target on Agilent Technologies to $150 From $130, Maintains Hold Rating	MT
11-25	Evercore ISI Adjusts Price Target on Agilent Technologies to $155 From $140, Maintains In Line Rating	MT
11-25	Barclays Adjusts Price Target on Agilent Technologies to $165 From $145, Maintains Equalweight Rating	MT
11-25	Leerink Partners Adjusts PT on Agilent Technologies to $165 From $140, Maintains Outperform Rating	MT
11-25	Baird Adjusts Price Target on Agilent Technologies to $165 From $142, Maintains Outperform Rating	MT
11-25	JPMorgan Adjusts Price Target on Agilent Technologies to $180 From $165, Maintains Overweight Rating	MT
11-25	Wells Fargo Adjusts Price Target on Agilent Technologies to $175 From $150, Maintains Overweight Rating	MT
11-25	Citigroup Adjusts Price Target on Agilent Technologies to $185 From $165, Maintains Buy Rating	MT
20/10/25	BofA Adjusts Price Target on Agilent Technologies to $150 From $130	MT
14/10/25	TD Cowen Adjusts Price Target on Agilent Technologies to $162 From $150, Maintains Buy Rating	MT
09/10/25	JPMorgan Adjusts PT on Agilent Technologies to $165 From $155, Maintains Overweight Rating	MT
08/10/25	Agilent Technologies 'Well Positioned' to Accelerate Sales Growth in 2027, UBS Says	MT
08/10/25	UBS Upgrades Agilent Technologies to Buy From Neutral, Raises Price Target to $170 From $130	MT
08/10/25	Rothschild & Co Redburn Initiates Agilent Technologies at Buy With $165 Price Target	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	AGILENT TECHNOLOGIES, INC.					+36.97%
	THERMO FISHER SCIENTIFIC, INC.					+32.87%
	INTUITIVE SURGICAL, INC.					+24.01%
	DANAHER CORPORATION					+28.37%
	BOSTON SCIENTIFIC CORPORATION					+37.35%
	SIEMENS HEALTHINEERS AG					+35.74%
	EDWARDS LIFESCIENCES CORPORATION					+23.01%
	RESMED, INC.					+16.28%
	GE HEALTHCARE TECHNOLOGIES INC.					+14.26%
	SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.					+49.72%
	Average					+29.86%
	Weighted average by Cap.					+29.84%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

126.94USD

Average target price

169.67USD

Spread / Average Target

+33.66%

High Price Target

185.00USD

Spread / Highest target

+45.74%

Low Price Target

150.00USD

Spread / Lowest Target

+18.17%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HSBC
Evercore ISI
Barclays
Morgan Stanley
Rothschild & Co Redburn
Stifel Nicolaus
UBS
TD Cowen
Wells Fargo Securities
Jefferies & Co.
Leerink Partners
Baird
JPMorgan Chase
Citigroup
BofA Securities
Bernstein
Goldman Sachs
Wolfe Research
Nephron Research
Credit Suisse
Morningstar
SVB Securities LLC
KeyBanc Capital Markets
Cowen
SVB Leerink
J.P. Morgan Chase